Literature DB >> 1370613

Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains.

F H Lin1, R Lin, H M Wisniewski, Y W Hwang, I Grundke-Iqbal, G Healy-Louie, K Iqbal.   

Abstract

Point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 (ND2) were detected in 10 of 19 Alzheimer's brains but not in 11 normal brains. The same mutations were also detected in 2 of 6 patients with amyotrophic lateral sclerosis (ALS). However, neurofibrillary tangles and neuritic plaques characteristic of Alzheimer's disease were found histologically in the brain of one ALS patient who was positive of the mutation. The finding suggests that a point mutation in ND2 is a potential risk factor for Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370613     DOI: 10.1016/s0006-291x(05)80136-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  31 in total

Review 1.  Genetic risk factors in Alzheimer's disease.

Authors:  L Tilley; K Morgan; N Kalsheker
Journal:  Mol Pathol       Date:  1998-12

2.  Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups.

Authors:  Corinna Herrnstadt; Joanna L Elson; Eoin Fahy; Gwen Preston; Douglass M Turnbull; Christen Anderson; Soumitra S Ghosh; Jerrold M Olefsky; M Flint Beal; Robert E Davis; Neil Howell
Journal:  Am J Hum Genet       Date:  2002-04-05       Impact factor: 11.025

3.  A variant of Leber hereditary optic neuropathy characterized by recovery of vision and by an unusual mitochondrial genetic etiology.

Authors:  D Mackey; N Howell
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

Review 4.  Does the mitochondrial DNA play a role in the pathogenesis of diabetes?

Authors:  K D Gerbitz
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

5.  A quantitative and specific method for measuring transcript levels of highly homologous genes.

Authors:  A J Lombardo; G B Brown
Journal:  Nucleic Acids Res       Date:  1996-12-01       Impact factor: 16.971

6.  Mutational analysis of whole mitochondrial DNA in patients with MELAS and MERRF diseases.

Authors:  Byung-Ok Choi; Jung Hee Hwang; Eun Min Cho; Eun Hye Jeong; Young Se Hyun; Hyeon Jeong Jeon; Ki Min Seong; Nam Soo Cho; Ki Wha Chung
Journal:  Exp Mol Med       Date:  2010-06-30       Impact factor: 8.718

Review 7.  Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas.

Authors:  Estela Area-Gomez; Cristina Guardia-Laguarta; Eric A Schon; Serge Przedborski
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

8.  Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ.

Authors:  H Lassmann; C Bancher; H Breitschopf; J Wegiel; M Bobinski; K Jellinger; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage.

Authors:  Maria Manczak; Byung S Park; Youngsin Jung; P Hemachandra Reddy
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

10.  Alzheimer neuropathology in mentally retarded adults: statistical independence of regional amyloid plaque and neurofibrillary tangle densities.

Authors:  W Silverman; E Popovitch; N Schupf; W B Zigman; A Rabe; E Sersen; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.